| Line 104: | Line 104: | ||
===2016-2020: [https://pubpeer.com/publications/E2628F04937D0DBD870E115CB41C8B E-cigarettes and smoking cessation in real-world and clinical settings: a systematic review and meta-analysis]=== | ===2016-2020: [https://pubpeer.com/publications/E2628F04937D0DBD870E115CB41C8B E-cigarettes and smoking cessation in real-world and clinical settings: a systematic review and meta-analysis]=== | ||
*Kalkhoran S, Glantz SA. E-cigarettes and smoking cessation in real-world and clinical settings: a systematic review and meta-analysis. Lancet Respir Med. 2016 Feb;4(2):116-28. doi: 10.1016/S2213-2600(15)00521-4. Epub 2016 Jan 14. PMID: 26776875; PMCID: PMC4752870. | |||
===2016: [https://pubpeer.com/publications/566A631490E2222E1E6DE4F44B6989 Chronic electronic cigarette exposure in mice induces features of COPD in a nicotine-dependent manner]=== | ===2016: [https://pubpeer.com/publications/566A631490E2222E1E6DE4F44B6989 Chronic electronic cigarette exposure in mice induces features of COPD in a nicotine-dependent manner]=== | ||
===2015: [https://journals.plos.org/plosone/article/comment?id=10.1371/annotation/5dfe1e98-3100-4102-a425-a647b9459456 Exposure to Electronic Cigarettes Impairs Pulmonary Anti-Bacterial and Anti-Viral Defenses in a Mouse Model]=== | ===2015: [https://journals.plos.org/plosone/article/comment?id=10.1371/annotation/5dfe1e98-3100-4102-a425-a647b9459456 Exposure to Electronic Cigarettes Impairs Pulmonary Anti-Bacterial and Anti-Viral Defenses in a Mouse Model]=== | ||
edits